Institute of Neural Injury and Rehabilitation

Home > Research > Institute of Neural Injury and Rehabilitation > Content

Institute of Neural Injury and Rehabilitation

Chen Hui

Chen Hui
Master of medicine. Director of Medical laboratory and China institute of rehabilitation medicine in China Rehabilitation Research Center(CRRC). Department of laboratory diagnosis in Capital University of Medical Sciences. PI at the Institute of nerve injury and rehabilitation in BIBD . Member of the Committee in Beijing anticancer association. Expert database member in Ministry of science and technology, National Natural Science Foundation Committee, Beijing, Zhejiang Province and Jiangsu Province.
During the period of Institute of rehabilitation medicine in CRRC , With urinary surgery ,bone joint surgery , spine surgery and neurology completed Beijing BoAi hospital’s "drug clinical trial institution qualification certification" in November 2007,  first to fill the blank of the China rehabilitation research center.
During the period of director of Medical laboratory of Beijing boai hospital in CRRC, accomplished ISO15189 quality management system accreditation in the 2008.Also completed the PCR laboratory accreditation,  experimental animals use license, and to accomplish " Key laboratory of Nerve Injury and Rehabilitation in The Beijing municipal science and technology commission” .
 The main research fields and papers
Neurobiology, including cell biology, molecular biology, proteomics, completed  BDNF, GDNF, NT-3, MBL and gene cloning and expression, bFGF gene modification and biological activity analysis, antigen and the monoclonal antibody preparation. ELISA and Gold tag technology research. Under the support of national financial special fund, To establish laboratory of cell biology, molecular biology laboratory, experimental animal laboratory and experimental pathology laboratories. Taken the research task of more than 40, papers published more than 50 , more than SCI 10 articles, Cooperative published book 2.
1、    Tu WJ, Zhao SJ, Xu DJ, Chen H. Serum 25-hydroxyvitamin D predicts the short-term outcomes of Chinese patients with acute ischemic stroke.. Clinical Science. 2014; 126(5): 339-46.
2、    Tu WJ, Liao XY, Dong Hao, Yan Yu, Yi Wang, Chen H. Phosphatidylinositol-3, 4, 5-trisphosphate 5-phosphatase 1: a meaningful and independent marker to predict stroke in Chinese population.  J Mol Neurosci. 2014, 52(4): 507–514.
3、    Tu WJ, Dong X, Zhao SJ, Yang DG,Chen H. Prognostic value of plasma neuroendocrine biomarkers in patients with acute ischemic stroke . Journal of Neuroendocrinology.2013,25(9): 771–778.
4、    Tu WJ, Zhao SJ, Liu TG, Yang DG, Chen H. Combination of high-sensitivity C-reactive protein and homocysteine predicts the short-term outcomes of Chinese patients with acute ischemic stroke Neurological Research.2013, 35(9):912-21.
5、    W.-J. Tu, X. Dong, S.-J. Zhao, D.-G. Yang and H. Chen.  Prognostic Value of Plasma Neuroendocrine Biomarkers in Patients with Acute Ischaemic Stroke.  Journal of Neuroendocrinology.  2013 September 25(9): 771–778.